Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Société Générale M&A Activity 2020

May 4, 2020

1671_mrq_2020-05-04_c0c1c34d-53e9-4201-9f33-8a8ae5dd81c0.html

M&A Activity

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

RNS Number : 7964L

Societe Generale SA

04 May 2020

Ap19

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1.       KEY INFORMATION

Name of person dealing (Note 1) Société Générale S.A.
Company dealt in Allergan plc
Class of relevant security to which the dealings being disclosed relate (Note 2) US$0.0001 ordinary shares
Date of dealing 01/05/2020

2.         INTERESTS AND SHORT POSITIONS

(a)        Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Long Short
Number (%) Number (%)
(1) Relevant securities 3,441,558 1.05 44,595 0.01
(2) Derivatives (other than options) 0 0.00 3,189,991 0.97
(3) Options and agreements to purchase/sell 58,500 0.02 0 0.00
Total *8,710,937 *2.65 3,234,586 0.98

* Include the holding of 5,210,879 shares on borrow products

(b)        Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security: Long Short
Number (%) Number (%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total

Ap20

1.       DEALINGS (Note 4)

(a)      Purchases and sales

Purchase/sale Number of relevant securities Price per unit USD (Note 5)
Purchase 666 189.74
Purchase 32 187.79
Purchase 37 189.74
Purchase 198 189.81
Purchase 18 189.05
Purchase 100 188.89
Purchase 15 189.44
Purchase 12 189.44
Purchase 100 187.83
Purchase 100 188.02
Purchase 182 189.74
Purchase 211 189.74
Purchase 277 189.74
Purchase 70 189.74
Purchase 371 189.74
Purchase 193 189.74
Purchase 2 189.74
Purchase 948 189.74
Purchase 82 189.74
Purchase 297 189.74
Purchase 13 189.74
Purchase 879 189.74
Purchase 1,075 189.74
Purchase 85 187.83
Purchase 15 187.83
Purchase 100 187.83
Purchase 100 188.94
Purchase 100 188.38
Purchase 100 189.07
Purchase 100 187.96
Purchase 11 189.25
Purchase 100 189.14
Purchase 100 189.15
Purchase 100 189.63
Purchase 22 189.25
Purchase 100 189.74
Purchase 100 187.97
Purchase 100 188.73
Purchase 12 188.99
Purchase 1 186.872
Purchase 3,546 189.74
Sale 99 189.74
Sale 200 187.5
Sale 100 187.35
Sale 100 187.33
Sale 26 187.38
Sale 47 187.21
Sale 38 187.12
Sale 14 186.77
Sale 13 186.8
Sale 100 186.76
Sale 99 187.98
Sale 44 186.57
Sale 22 186.63
Sale 12 187.56
Sale 49 187.56
Sale 45 186.72
Sale 23 189.4
Sale 2 189.54
Sale 2 189.54
Sale 3 189.54
Sale 1 189.54
Sale 13 189.54
Sale 12 189.54
Sale 12 189.54
Sale 2 189.54
Sale 3 189.54
Sale 3 189.54
Sale 1 189.54
Sale 100 189.81
Sale 100 189.52
Sale 100 189.52
Sale 100 189.77
Sale 20 188.79
Sale 100 187.8
Sale 40 189.26
Sale 45 187.18
Sale 100 187.5
Sale 100 187.56
Sale 18 187.52
Sale 23 189.33
Sale 100 189.34
Sale 35 189.84
Sale 30 189.84
Sale 51 189.74
Sale 940 187.73307
Sale 1 189.2
Sale 21 189.2
Sale 100 187.36
Sale 100 189.28
Sale 50 189.19
Sale 50 189.2
Sale 100 189.73
Sale 100 189.5
Sale 670 188.07139
Sale 100 189.31
Sale 100 189.21
Sale 65 189.12
Sale 35 189.12
Sale 100 189.12
Sale 100 186.46
Sale 100 189.64
Sale 100 189.82
Sale 1 189.53
Sale 100 189.64
Sale 11 189.33
Sale 11 189.33
Sale 100 189.52
Sale 100 189.26
Sale 51 187.34
Sale 49 187.34
Sale 100 189.4
Sale 100 189.26
Sale 2 189.42
Sale 100 189.41
Sale 100 188.7
Sale 13 189.18
Sale 87 189.18
Sale 11 189.25
Sale 11 189.33
Sale 100 189.51
Sale 100 188.27
Sale 100 188.48
Sale 100 189.38
Sale 100 189.5
Sale 100 189.36
Sale 11 189.2
Sale 16 189.36
Sale 84 189.36
Sale 3 188.23
Sale 97 188.23
Sale 1 189.21
Sale 99 189.21
Sale 100 189.23
Sale 60 188.55
Sale 100 188.27
Sale 25 189.73
Sale 10 189.73
Sale 100 189.46
Sale 28 189.55
Sale 34 189.86
Sale 66 189.86
Sale 72 189.55
Sale 3 188.62
Sale 13 188.62
Sale 3 188.62
Sale 100 189.33
Sale 100 189.36
Sale 10 188.62
Sale 20 188.62
Sale 100 188.41
Sale 100 189.74
Sale 7,567 189.58693
Sale 35 189.74
Sale 220 187.44486
Sale 1,600 188.71526
Sale 49 189.83
Sale 50 189.84
Sale 11 187.33
Sale 11 187.33
Sale 100 187.35
Sale 100 187.9
Sale 100 189.16
Sale 47 187.19
Sale 53 187.19
Sale 100 186.86
Sale 100 189.89
Sale 100 187.97
Sale 100 188.03
Sale 1 189.6
Sale 99 189.6
Sale 100 189.84
Sale 100 189.3
Sale 100 189.85
Sale 89 189.71
Sale 11 189.71
Sale 100 189.73
Sale 60 189.65
Sale 100 189.65
Sale 95 189.44
Sale 72 189.56
Sale 100 189.72
Sale 43 189.74
Sale 99 189.79
Sale 76 189.46
Sale 12 189.46
Sale 40 189.65
Sale 23 189.60191
Sale 5,319 189.74
Sale 1,405 189.50982
Total Purchases 10,670
Total Sales 26,268

(b)      Derivatives transactions (other than options transactions)

Product name,

e.g. CFD
Nature of transaction

(Note 6)
Number of relevant securities

(Note 7)
Price per unit USD

(Note 5)

(c)      Options transactions in respect of existing relevant securities

(i)       Writing, selling, purchasing or varying

Product name,

e.g. call option
Writing, selling, purchasing, varying etc. Number of securities to which the option relates (Note 7) Exercise price Type, e.g. American, European etc. Expiry date Option money paid/received per unit (Note 5)

(ii)      Exercising

Product name,

e.g. call option
Number of securities Exercise price per unit (Note 5)

(d)      Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)
Details Price per unit

(if applicable) (Note 5)

Ap21

2.       OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and 

any other person relating to the voting rights of any relevant securities under any option referred to 

on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to 

which any derivative referred to on this form is referenced. If none, this should be stated.

Is a Supplemental Form 8 attached? (Note 9)                                            Yes

Date of disclosure 04/05/2020
Contact name Société Générale - Disclosure team
Telephone number +33 1 42 14 92 74
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection (Note 10)

Ap23

SUPPLEMENTAL FORM 8

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL 

ACT, 1997, TAKEOVER RULES, 2013

DETAILS OF OPEN POSITIONS

(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)

OPEN POSITIONS (Note 1)

Product name,

e.g. call option
Written, or purchased Number of relevant securities to which the option or derivative relates Exercise price (Note 2) Type, e.g. American, European etc. Expiry date
Listed Put Option Sale 40,000 175 American options 15/01/2021
Listed Put Option Sale 18,500 190 American options 15/01/2021

Notes

1.          Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.

2.          For all prices and other monetary amounts, the currency must be stated.

For full details of disclosure requirements, see Rule 8 of the 

Rules. If in doubt, consult the Panel.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

ISEKKQBBOBKKPPK